Kanada - Englisch - Health Canada

novartis pharmaceuticals canada inc - travoprost - solution - 0.004% - travoprost 0.004% - prostaglandin analogs

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

novartis pharmaceuticals corporation - travoprost (unii: wj68r08kx9) (travoprost - unii:wj68r08kx9) - travatan z® (travoprost ophthalmic solution) 0.004% is indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. none. risk summary there are no adequate and well-controlled studies in pregnant women to inform a drug-associated risk. in animal reproduction studies, subcutaneous (sc) administration of travoprost to pregnant mice and rats throughout the period of organogenesis produced embryo-fetal lethality, spontaneous abortion, and premature delivery at potentially clinically relevant doses. advise pregnant women of a potential risk to a fetus. because animal reproductive studies are not always predictive of human response, travatan z should be administered during pregnancy only if the potential benefit justifies the potential risk to the fetus. the background risk of major birth defects and miscarriage for the indicated population is unknown; however, in the u.s. general population, the estimated background risk of major birth defects is

Kenia - Englisch - Pharmacy and Poisons Board

indoco remedies limited "indoco house, 166, cst road, santacruz (east), - travoprost - eye drops - each ml contains: travoprost 0.04 mg - travoprost

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - travoprost 40 µg/ml;   - eye drops, solution - 40 mcg/ml - active: travoprost 40 µg/ml   excipient: benzalkonium chloride boric acid disodium edetate dihydrate hydrochloric acid mannitol polyethylene glycol hydrogenated castor oil purified water sodium hydroxide trometamol - travatan eye drops are indicated to decrease elevated intraocular pressure in: · ocular hypertension · open-angle glaucoma as monotherapy or as adjunctive therapy.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - travoprost -